Skip to main content
. 2021 Dec 2;11:23301. doi: 10.1038/s41598-021-02767-1

Figure 3.

Figure 3

The effect of the presence of FLT3-ITD mutation on telomere length and survival in patients below 61 years of age. Kaplan-Meier curves for overall survival in patients stratified with respect to the presence of FLT3-ITD mutation. Gehan-Breslow-Wilcoxon test was used for statistical analysis (a). Differences in median telomere length in AML patients having or lacking FLT3-ITD mutation assessed by Mann-Whitney U test (b).